Inhibikase Therapeutics (IKT) Shareholder's Equity (2020 - 2026)
Inhibikase Therapeutics (IKT) Shareholder's Equity (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Shareholder's Equity (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
7.14 Bn |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
795.79 Mn |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
595,226.00 |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
1.00 Bn |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
14.38 Mn |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
19.36 Bn |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
502.95 Mn |
| 10 |
Inhibikase Therapeutics |
285.17 Mn |
114.80 Mn |
- |
167.62 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
167.62 Mn |
| Dec 31, 2025 |
172.90 Mn |
| Sep 30, 2025 |
72.90 Mn |
| Jun 30, 2025 |
80.05 Mn |
| Mar 31, 2025 |
85.73 Mn |
| Dec 31, 2024 |
94.87 Mn |
| Sep 30, 2024 |
-530,591.00 |
| Jun 30, 2024 |
5.10 Mn |
| Mar 31, 2024 |
6.78 Mn |
| Dec 31, 2023 |
10.98 Mn |
| Sep 30, 2023 |
15.02 Mn |
| Jun 30, 2023 |
19.46 Mn |
| Mar 31, 2023 |
25.28 Mn |
| Dec 31, 2022 |
21.04 Mn |
| Sep 30, 2022 |
25.14 Mn |
| Jun 30, 2022 |
29.50 Mn |
| Mar 31, 2022 |
34.01 Mn |
| Dec 31, 2021 |
38.42 Mn |
| Sep 30, 2021 |
43.16 Mn |
| Jun 30, 2021 |
47.05 Mn |
